Has Anyone Kept the Weight Off After Stopping Mounjaro?

Last reviewed: July 11, 2026

Last updated: July 11, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Clinical data shows that roughly 70% of people regain two-thirds of lost weight within one year of stopping GLP-1 receptor agonist medications like Mounjaro. The underlying biology explains why: these drugs work by activating appetite-suppressing pathways in your brain and gut, and those signals fade when the medication stops. Understanding weight regain patterns helps inform better long-term weight management strategies.

Why Weight Returns After Stopping Mounjaro

Mounjaro (tirzepatide) works by mimicking two hormones—GLP-1 and GIP—that tell your brain you're full and satisfied. When you take the injection weekly, these signals stay active. The moment you stop the medication, your brain no longer receives those "stop eating" messages, and your appetite often rebounds to pre-treatment levels within weeks. Your body's baseline hunger set point hasn't permanently shifted; the medication was doing the signaling work for you.

The PlexusDx Precision Peptide Genetic Test analyzes GLP1R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Mounjaro or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

What Research Shows About Long-Term Weight Maintenance

Major clinical trials including SURMOUNT-4 and SURPASS-4 tracked participants after they stopped tirzepatide or semaglutide. Results consistently showed that weight loss was not maintained—participants returned toward baseline body weight within months. However, those who stayed on ongoing therapy (even at lower maintenance doses) kept 80–90% of their weight loss intact. This evidence strongly suggests that GLP-1 and tirzepatide medications work best as ongoing treatments rather than short-term interventions.

The data also revealed that rebound weight gain often accelerates in the second and third months off medication, meaning people don't gradually slip—they tend to gain rapidly. Interestingly, if people restarted the medication after stopping, they typically needed higher doses or longer titration periods to regain the same level of appetite suppression they had achieved before. Continuous therapy appears to be more effective and efficient than repeated stop-and-start cycles.

How Continuous GLP-1 Therapy Differs From On-Off Cycles

Staying on a consistent dose of tirzepatide or semaglutide maintains the appetite-control signals your brain relies on to stay satisfied with smaller portions. You never experience the rebound hunger spike, and your eating patterns remain stable. Many people find that continuous therapy is simpler psychologically—there's no "end date" that triggers anxiety about regaining weight, and no restart period where you're dealing with side effects again.

PlexusDx offers compounded tirzepatide injection starting at $289/mo (or $249/mo on the 6-month plan) (flat pricing regardless of dose) from licensed 503A compounding pharmacies. The consistent, affordable access removes barriers to staying on therapy long-term. HSA and FSA accounts cover the cost, and no insurance or membership is required. Some patients also benefit from PlexusDx's Microdose GLP-1 Protocol at $129/month for those who need appetite support at a lower dose level, offering flexibility in long-term management.

Managing Weight Regain If You Do Stop Treatment

If stopping medication is medically necessary or your choice, several strategies can slow (though not prevent) weight regain. Maintaining the dietary and exercise habits you built while on the medication is critical—even without the drug's appetite-suppressing effect, staying active and eating whole foods helps. Some people benefit from behavioral support, food journaling, or working with a nutritionist to reinforce the skills learned during active weight loss.

Restarting GLP-1 therapy at the first sign of significant regain may be more effective than waiting months for weight to fully return. If you do restart, having your genetic data on hand (from the PlexusDx Precision Peptide Genetic Test, a $99 add-on) can help identify the best compound and dose strategy for your individual peptide pathways. This personalized approach often leads to faster response and more stable long-term outcomes than repeating a standard protocol.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $289/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Has anyone successfully kept weight off permanently after stopping Mounjaro?

Very few people maintain weight loss permanently after stopping without significant lifestyle intervention. Studies show most regain 60–70% of lost weight within a year. Successful long-term maintenance typically requires ongoing medication, consistent exercise, and sustained dietary changes rather than a medication-only approach or stopping entirely.

How quickly does weight come back after stopping Mounjaro?

Weight regain typically begins within 2–4 weeks and accelerates over the next 2–3 months. Most regain occurs in the first 6 months, with people returning close to baseline weight by month 12. The speed varies based on genetics, diet adherence, and activity level, but rebound is usually faster than the initial weight loss was.

Is it better to stay on tirzepatide long-term than to stop and restart?

Clinical evidence strongly favors continuous therapy. Staying on medication maintains appetite control, avoids rebound hunger spikes, and typically requires lower doses for long-term maintenance than restarting after a break. PlexusDx compounded tirzepatide injection starts at $289/mo (or $249/mo on the 6-month plan) flat pricing, making continuous access affordable without insurance or membership requirements.

Can you eventually stop GLP-1 medication without regaining weight?

Not reliably based on current evidence. While some individuals with significant lifestyle changes may maintain partial weight loss, most people require ongoing medication to prevent substantial regain. GLP-1 drugs address the biological drive to eat; stopping removes that biological support unless your brain's appetite regulation has permanently reset (which rarely happens).

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to GLP-Squared or any specific medication. It analyzes pathway-level variants (GLP1R, and GIPR) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Mounjaro For Losing Weight
• Mounjaro For Weight Loss 2
• Weight Loss Mounjaro
• Mounjaro Weight Loss By Week

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.